Page last updated: 2024-09-04

ezetimibe and Glucose Metabolic Disorder

ezetimibe has been researched along with Glucose Metabolic Disorder in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arita, E; Honda, A; Horai, Y; Irie, J; Itoh, H; Kaneko-Iwasaki, N; Miyazaki, T; Morimoto, K; Sugizaki, T; Watanabe, M	1

Other Studies

1 other study(ies) available for ezetimibe and Glucose Metabolic Disorder

Article	Year
The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice. Endocrinology, 2014, Volume: 155, Issue:8 Topics: Animals; Anticholesteremic Agents; Azetidines; Cells, Cultured; Diet, High-Fat; Ezetimibe; Fatty Liver; Glucose Metabolism Disorders; Hepatocytes; Intestinal Mucosa; Intestines; Lipid Metabolism; Liver X Receptors; Male; Membrane Transport Proteins; Mice; Mice, Obese; Orphan Nuclear Receptors; Rats; Rats, Sprague-Dawley; Stearoyl-CoA Desaturase	2014

Article

Year

The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.

Endocrinology, 2014, Volume: 155, Issue:8

Topics: Animals; Anticholesteremic Agents; Azetidines; Cells, Cultured; Diet, High-Fat; Ezetimibe; Fatty Liver; Glucose Metabolism Disorders; Hepatocytes; Intestinal Mucosa; Intestines; Lipid Metabolism; Liver X Receptors; Male; Membrane Transport Proteins; Mice; Mice, Obese; Orphan Nuclear Receptors; Rats; Rats, Sprague-Dawley; Stearoyl-CoA Desaturase

2014